Top Vaccines companies in France by Revenue

This ranking features the top 5 Vaccines companies in France ranked by Revenue, totalling a Revenue of USD 51.00 B, for January 15, 2025.

France

Vaccines
Revenue
#
Name
Revenue
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
SAN.PA

Sanofi

1

SAN.PA
USD 50.81 B
Dec. 31, 2023 USD 96.09 -1.23%

France
2
VLA.PA

Valneva SE

2

VLA.PA
USD 169.66 M
Dec. 31, 2023 USD 2.16 -2.19%

France
3
DBVT

DBV Technologies S.A.

3

DBVT
USD 15.73 M
Dec. 31, 2023 USD 4.64 -14.23%

France
4
OSE.PA

OSE Immunotherapeutics SA

4

OSE.PA
USD 2.46 M
Dec. 31, 2023 USD 6.91 0.46%

France
5
ALNEV.PA

Neovacs S.A.

5

ALNEV.PA
USD 588.75 K
Dec. 31, 2023 USD 0.96 -6.39%

France
Frequently Asked Questions
  • Which Vaccines company in France has the highest Revenue ?

    The Vaccines company in France with the highest Revenue is Sanofi (Paris Stock Exchange: SAN.PA) at USD 50.81 B.

  • Which Vaccines company in France has the lowest Revenue ?

    The Vaccines company in France with the lowest Revenue is Neovacs S.A. (Paris Stock Exchange: ALNEV.PA) at USD 588.75 K.